EUVIMEDEUVIMED entdecken
Crossref

OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION VERSUS CHEMOTHERAPY ALONE FOR RESECTED DISTAL PANCREATIC ADENOCARCINOMA

D Patel, H Hosseinpour, D. Patel

HPB · 2026 · 28 · S30-S31

DOI: 10.1016/j.hpb.2026.04.049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HPB, 2026. Verfasst von D Patel und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Patel, D., Hosseinpour, H., & Patel, D. (2026). OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION VERSUS CHEMOTHERAPY ALONE FOR RESECTED DISTAL PANCREATIC ADENOCARCINOMA. HPB, 28, S30-S31. https://doi.org/10.1016/j.hpb.2026.04.049

Vancouver

Patel D, Hosseinpour H, Patel D. OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION VERSUS CHEMOTHERAPY ALONE FOR RESECTED DISTAL PANCREATIC ADENOCARCINOMA. HPB. 2026;28:S30-S31. doi:10.1016/j.hpb.2026.04.049

BibTeX
@article{Patel2026,
  author = {Patel, D and Hosseinpour, H and Patel, D.},
  title = {OUTCOMES FOLLOWING NEOADJUVANT CHEMORADIATION VERSUS CHEMOTHERAPY ALONE FOR RESECTED DISTAL PANCREATIC ADENOCARCINOMA},
  journal = {HPB},
  year = {2026},
  volume = {28},
  pages = {S30--S31},
  doi = {10.1016/j.hpb.2026.04.049}
}
Kostenlos starten →